FXYD6 and colorectal carcinoma: To understand FXYD6 expression in CRC, we firstly analyzed the data including 41 normal tissue samples and 286 primary tumor tissue samples from TCGA; the expression levels of FXYD6 in tumor samples were observably decreased (Figure 1(b)).